Theravance Biopharma, Inc. - Ordinary Shares — Cash Flow (NASDAQ:TBPH) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -250.4 M-207.86 M-186.99 M-27 M-11.54 M238.54 M 53.74 M Cash from investing activities 10.72 M124.49 M1.15 B-32.7 M12.28 M-105.28 M -107.47 M Cash from financing activities 263.08 M91.86 M-758.81 M-198.93 M-2.5 M-3.25 M -8.44 M Free cash flow -257.02 M-211.26 M-187.56 M-29.48 M-11.87 M238.5 M 53.73 M

News

TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

Stevanato Group (STVN) Q2 Earnings Top Estimates

Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates

Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates

Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME)

Theravance Stock Down 3% After Zymeworks Announces Buyout

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

Are Options Traders Betting on a Big Move in Theravance Biopharma Stock?

TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle

Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates